Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes (Q87207661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

ChEBI release 2020-05-28

1 reference

Sin Young Choi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yuhee Ryu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hae Jin Kee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Soo-Na Cho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gwi Ran Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jae Yeong Cho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hyung-Seok Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

In-Kyeom Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Myung Ho Jeong

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

25 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

130-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

Inflammation in hypertension: current therapeutic approaches.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Fli1 represses transcription of the human α2(I) collagen gene by recruitment of the HDAC1/p300 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Fibroblast growth factor 23 in acute kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Molecular targets for treatment of kidney fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Epigenetics in sepsis: targeting histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

7 January 2021

HDAC6 and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Smad transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Inflammatory processes in renal fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Connective Tissue Growth Factor Expressed in Tubular Epithelium Plays a Pivotal Role in Renal Fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Renal function and target organ damage in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

TGF-beta signaling in vascular fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Potential approaches to reverse or repair renal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Plasma and cellular fibronectin: distinct and independent functions during tissue repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Risk stratification of resistant hypertension in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Activin A is a potent activator of renal interstitial fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.04.006

10.1016/J.VPH.2015.04.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921924%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference